78.64

0.40% 0.31

Pre-market: 78.70 0.06 +0.08%

Nuvalent Inc (NUVL)

Overview News Price History Option Chain Financials Why NUVL Down? Discussions Forecast

Nuvalent Inc stock is traded at $78.64, with a volume of 308.65K. It is up +0.40% in the last 24 hours and up +3.42% over the past month. Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Previous Close:

$78.33

Open:

$78.83

24h Volume:

308.65K

Relative Volume:

0.64

Market Cap:

$5.24B

Revenue:

Net Income/Loss:

$-224.29M

P/E Ratio:

-20.16

EPS:

-3.9

Net Cash Flow:

$-185.06M

1W Performance:

+0.18%

1M Performance:

+3.42%

6M Performance:

+2.10%

1Y Performance:

-24.93%

1-Day Range:

$78.45

$81.28

1-Week Range:

$77.88

$83.09

52-Week Range:

$55.53

$108.98

Nuvalent Inc Stock (NUVL) Company Profile

Name

Nuvalent Inc

Sector

Healthcare (1145)

Industry

Biotechnology (643)

Phone

508-446-2272

Address

ONE BROADWAY, 14TH FLOOR, CAMBRIDGE

Employee

200

Twitter

Next Earnings Date

Latest SEC Filings

NUVL's Discussions on Twitter

Compare NUVL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NUVL Nuvalent Inc	78.64	5.65B	0	-224.29M	-185.06M	-3.90
VRTX Vertex Pharmaceuticals Inc	387.15	100.34B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	585.50	60.95B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	451.73	60.46B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	734.35	46.04B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	332.20	36.02B	3.81B	-644.79M	-669.77M	-6.24

Nuvalent Inc Stock (NUVL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-04-25	Resumed	Guggenheim	Buy
Sep-03-25	Initiated	Raymond James	Outperform
Aug-19-25	Initiated	Piper Sandler	Overweight
Mar-14-25	Upgrade	UBS	Neutral → Buy
Dec-30-24	Initiated	H.C. Wainwright	Buy
Oct-24-24	Initiated	UBS	Neutral
Aug-29-24	Initiated	Barclays	Overweight
Apr-17-24	Initiated	Jefferies	Buy
Apr-01-24	Upgrade	Leerink Partners	Market Perform → Outperform
Feb-28-24	Resumed	Guggenheim	Buy
Feb-23-24	Initiated	Robert W. Baird	Outperform
Sep-27-23	Initiated	Stifel	Buy
Aug-08-23	Initiated	SVB Securities	Market Perform
Jul-24-23	Initiated	Guggenheim	Buy
Jan-18-23	Initiated	Wedbush	Outperform
Jun-24-22	Initiated	BMO Capital Markets	Outperform

View All

Nuvalent Inc Stock (NUVL) Latest News

Sep 17, 2025

Nuvalent (NASDAQ:NUVL) Insider Sells $293,641.75 in Stock - MarketBeat

Sep 17, 2025

Nuvalent (NUVL): Assessing Valuation Following Subtle Shifts in Investor Sentiment - Yahoo Finance

Sep 17, 2025

Sep 16, 2025

Surprises Report: Should I buy Nuvalent Inc stock nowMarket Sentiment Summary & Stepwise Trade Signal Implementation - خودرو بانک

Sep 16, 2025

Aug Selloffs: Is Nuvalent Inc stock a value trap2025 Pullback Review & Consistent Income Trade Recommendations - خودرو بانک

Sep 16, 2025

Aug Levels: Is Nuvalent Inc stock a value trapWeekly Stock Analysis & Risk Controlled Stock Alerts - خودرو بانک

Sep 16, 2025

Dividend Watch: Should I set a stop loss on Nuvalent IncJuly 2025 Levels & AI Forecast Swing Trade Picks - خودرو بانک

Sep 16, 2025

Stock Analysis: Should I buy Nuvalent Inc stock now2025 Market Sentiment & Free Verified High Yield Trade Plans - خودرو بانک

Sep 16, 2025

Tech Rally: Can RFAI grow without external fundingJuly 2025 Sentiment & High Conviction Investment Ideas - خودرو بانک

Sep 16, 2025

RSI Check: Is Nuvalent Inc. showing insider buyingMarket Volume Summary & Consistent Profit Trade Alerts - خودرو بانک

Sep 16, 2025

CEO Change: Is Nuvalent Inc benefiting from innovation trendsQuarterly Performance Summary & Reliable Price Breakout Alerts - خودرو بانک

Sep 16, 2025

Sep 15, 2025

Trade Report: Is FVAM affected by consumer sentimentMarket Volume Report & Daily Growth Stock Investment Tips - خودرو بانک

Sep 15, 2025

Market Outlook: Is Nuvalent Inc benefiting from innovation trends2025 Biggest Moves & Fast Gain Swing Alerts - خودرو بانک

Sep 15, 2025

Stock Analysis: What makes Nuvalent Inc. stock attractive todayJuly 2025 Spike Watch & Fast Gain Swing Trade Alerts - خودرو بانک

Sep 15, 2025

Is Nuvalent Inc. in a bullish channel2025 Retail Activity & Consistent Growth Equity Picks - خودرو بانک

Sep 15, 2025

Rhumbline Advisers Has $3.76 Million Holdings in Nuvalent, Inc. $NUVL - Defense World

Sep 15, 2025

Fred Alger Management LLC Sells 120,155 Shares of Nuvalent, Inc. $NUVL - MarketBeat

Sep 15, 2025

20,994 Shares in Nuvalent, Inc. $NUVL Purchased by Voleon Capital Management LP - MarketBeat

Sep 15, 2025

Sep 14, 2025

Is Nuvalent Inc. reversing from oversold territoryJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com

Sep 14, 2025

Nuvalent (NASDAQ:NUVL) Given "Outperform" Rating at Wedbush - MarketBeat

Sep 14, 2025

Sep 13, 2025